Joseph Y. Chang - Feb 11, 2022 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
Chief Scientific Officer
Signature
/s/ Gregory Belliston as Attorney-in-Fact for Joseph Y. Chang
Stock symbol
NUS
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 03:41 PM
Previous filing
Sep 13, 2021
Next filing
Feb 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUS Employee Stock Option (Right to Buy) Award $0 +33.1K +100.01% $0.00 66.1K Feb 11, 2022 Class A Common Stock 33.1K $30.45 Direct F1
transaction NUS Employee Stock Option (Right to Buy) Award $0 +10.8K $0.00 10.8K Feb 11, 2022 Class A Common Stock 10.8K $48.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.
F2 On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.